Ureteral Stents Market Share, Growth and Trends Analysis 2025-2033

Global Ureteral Stents Market Statistics: USD 619.2 Million Value by 2033 Summary: <ul> <li>The global <a target="_blank" rel="noopener noreferrer" href="https://www.imarcgroup.com/ureteral-stents-market">ureteral stents market</a> size reached USD 395.5 Million in 2024.</li> <li>The market is expected to reach USD 619.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.06% during 2025-2033.</li> <li>Asia Pacific leads the market, accounting for the largest ureteral stents market share.</li> <li>Double J-stents exhibit a clear dominance in the market due to their widespread use and efficacy in treating ureteral obstructions and facilitating urine flow.</li> <li>Kidney stones hold the biggest market share attributed to the increasing prevalence of kidney stones, which necessitate frequent use of ureteral stents for treatment and management.</li> <li>Innovations, such as biodegradable stents, drug-eluting stents, and those with anti-reflux properties, are enhancing patient outcomes and comfort.</li> <li>The increasing prevalence of urological disorders, such as kidney stones, urinary tract infections (UTIs), and strictures, among the masses is propelling the market growth.</li> </ul> Industry Trends and Drivers: <ul> <li>Technological Advancements in Ureteral Stent Design:</li> </ul> New technologies are enhancing patient care. Biodegradable stents reduce doctors' workload and improve comfort. Drug-eluting stents prevent infections and blood clots. Anti-reflux stents stop urine from leaking onto patients. These advancements make ureteral stents safer, more effective, and user-friendly. <ul> <li>Rising Incidence of Urological Disorders:</li> </ul> The incidence of kidney stones, urinary stones and strictures is on the rise, increasing the need for urology devices. Factors such as obesity, poor diet and increasing age contribute to this increase. These conditions often require stents to prevent urinary obstruction. With many patients requiring treatment, the use of ureteral stents is on the rise. These stents help manage obstructive uropathy. <ul> <li>Rising Awareness and Screening Programs:</li> </ul> Many health ministries and organizations sponsor awareness programs. These programs stress the importance of recognizing and managing urological disorders. Screening is vital in areas with limited access. It allows for early detection of kidney stones, strictures, and tumors. Early detection simplifies treatment. Urinary blockages often need ureteral stents. Timely diagnosis of kidney disorders is crucial. Overall, urological health is on the rise. More patients seek treatment at the first sign of issues, including those needing ureteral stents. Request for a sample copy of this report: <a target="_blank" rel="noopener noreferrer" href="https://www.imarcgroup.com/ureteral-stents-market/requestsample"><a target="_blank" rel="nofollow noopener">https://www.imarcgroup.com/ureteral-stents-market/requestsample</a></a> Ureteral Stents Market Report Segmentation: By Product Type: <ul> <li>Open End Stents</li> <li>Closed End Stents</li> <li>Double J-Stent</li> <li>Multiloop Stents</li> </ul> Double J-stents exhibit a clear dominance in the market due to their widespread use and efficacy in treating ureteral obstructions and facilitating urine flow. By Material: <ul> <li>Metallic Ureteral Stents</li> <li>Polymer Ureteral Stents</li> <li>Silicone Stents</li> <li>Polyurethane Stents</li> <li>Hybrid Stents</li> </ul> Polymer ureteral stents (silicone stents, polyurethane stents, and hybrid stents) represent the largest segment owing to their flexibility, biocompatibility, and cost-effectiveness compared to metal stents. By Application: <ul> <li>Kidney Stones</li> <li>Kidney Transplantation</li> <li>Tumors</li> <li>Urinary Incontinence</li> <li>Others</li> </ul> Kidney stones hold the biggest market share attributed to the increasing prevalence of kidney stones, which necessitate frequent use of ureteral stents for treatment and management. By End Use: <img src="https://www.diveboard.com/user_images/original-image-360734.jpeg" width="1280" height="720"> <ul> <li>Hospitals and Clinics</li> <li>Ambulatory Surgical Centers (ASCs)</li> <li>Others</li> </ul> Hospitals and clinics account for the majority of the market share accredited to the high volume of urological procedures performed in these settings requiring ureteral stent placement. Regional Insights: <ul> <li>North America (United States, Canada)</li> <li>Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)</li> <li>Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)</li> <li>Latin America (Brazil, Mexico, Others)</li> <li>Middle East and Africa</li> </ul> North America dominates the market on account of the advanced healthcare infrastructure, high prevalence of urological conditions, and rising healthcare expenditure. Top Ureteral Stents Market Leaders: The ureteral stents market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are: <a target="_blank" rel="noopener noreferrer" href="https://_wp_link_placeholder" data-wplink-edit="true"><img src="https://www.diveboard.com/user_images/original-image-360735.jpeg" width="883" height="497"></a> <ul> <li>Allium Medical Solutions Ltd.</li> <li>B. Braun Melsungen AG</li> <li>Biomerics</li> <li>Boston Scientific Corporation</li> <li>Becton, Dickinson and Company</li> <li>Coloplast Ltd.</li> <li>Cook Group Incorporated</li> <li>Medline Industries Inc.</li> <li>Merit Medical Systems Inc.</li> <li>Olympus Corporation</li> <li>Teleflex Incorporated</li> </ul> Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization. About Us: IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. Contact Us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1-631-791-1145